Galen see revenue up 84% in year

Galen reported today that full-year total pharmaceutical product revenues increased by 84% to $432.3m (€375m) from $235.2m (€204m) to beat analysts’ forecasts.

Pre-tax profit at the Craigavon, Northern Ireland, based company fell to $116.3m (€100m) from $149.4m (€129m), however.